Randomized phase II study of S-1 plus oral leucovorin (SL) versus SL plus oxaliplatin (SOL) versus S-1 plus cisplatin (SP) in patients with advanced gastric cancer (AGC): Update data

被引：0
|
作者：
Komatsu, Y. [1 ]
Shuichi, H. [2 ]
Naotoshi, S. [3 ]
Kensei, Y. [4 ]
Toshikazu, M. [5 ]
Tomohiro, N. [6 ]
Akihito, T. [7 ]
Takako, E. N. [8 ]
Masahiro, G. [9 ]
Nozomu, M. [10 ]
Hideaki, B. [11 ]
Taito, E. [12 ]
Yasunori, E. [13 ]
Takashi, S. [14 ]
Shigemi, M. [15 ]
Narikazu, B. [8 ]
Hideo, B. [16 ]
Ichinosuke, H. [5 ]
机构：
[1] Hokkaido Univ Hosp, Canc Chemotherapy, Ctr Canc, Sapporo, Hokkaido 060, Japan
[2] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba 2608717, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Clin Oncol, Osaka, Japan
[4] Saitama Canc Ctr, Div Gastroenterol, Saitama, Japan
[5] Univ Tsukuba, Div Gastroenterol, Tsukuba, Ibaraki, Japan
[6] Natl Hosp Org, Shikoku Canc Ctr, Dept Gastroenterol, Matsuyama, Ehime, Japan
[7] Kobe City Med Ctr, Gen Hosp, Dept Med Oncol, Kobe, Hyogo, Japan
[8] St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan
[9] Osaka Med Coll Hosp, Ctr Canc Chemotherapy, Osaka, Japan
[10] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[11] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
[12] Natl Kyusyu Canc Ctr, Clin Res Inst, Fukuoka, Japan
[13] Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan
[14] Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Yokohama, Kanagawa, Japan
[15] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Kyoto, Japan
[16] Kumamoto Univ, Dept Surg Gastroenterol, Kumamoto, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31255-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2339
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [1] S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial
    Hironaka, Shuichi
    Sugimoto, Naotoshi
    Yamaguchi, Kensei
    Moriwaki, Toshikazu
    Komatsu, Yoshito
    Nishina, Tomohiro
    Tsuji, Akihito
    Nakajima, Takako Eguchi
    Gotoh, Masahiro
    Machida, Nozomu
    Bando, Hideaki
    Esaki, Taito
    Emi, Yasunori
    Sekikawa, Takashi
    Matsumoto, Shigemi
    Takeuchi, Masahiro
    Boku, Narikazu
    Baba, Hideo
    Hyodo, Ichinosuke
    LANCET ONCOLOGY, 2016, 17 (01): : 99 - 108
  • [2] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Yamada, Yasuhide
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Negoro, Yuji
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirotumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hamada, Chikuma
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [3] A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC)
    Hosokawa, A.
    Ogawa, K.
    Kajiura, S.
    Tsukioka, Y.
    Kobayashi, T.
    Horikawa, N.
    Kobayashi, Y.
    Yoshioka, A.
    Sumi, S.
    Sugiyama, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [4] Randomized phase II study comparing S-1 plus Leucovorin (SL) versus S-1 alone in patients with gemcitabine-refractory advanced pancreatic cancer (APC)
    Okusaka, T.
    Ueno, M.
    Omuro, Y.
    Isayama, H.
    Fukutomi, A.
    Ikeda, M.
    Mizuno, N.
    Fukuzawa, K.
    Hyodo, I.
    Boku, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S611 - S611
  • [5] Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin
    Nishikawa, Kazuhiro
    Yamada, Yasuhide
    Ishido, Kenji
    Gotoh, Masahiro
    Bando, Hideaki
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Tsuji, Akihito
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirofumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hironaka, Shuichi
    Shimada, Ken
    Miwa, Hiroto
    Hamada, Chikuma
    Hyodo, Ichinosuke
    GASTRIC CANCER, 2017, 20 (04) : 640 - 645
  • [6] Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin
    Kazuhiro Nishikawa
    Yasuhide Yamada
    Kenji Ishido
    Masahiro Gotoh
    Hideaki Bando
    Naotoshi Sugimoto
    Tomohiro Nishina
    Kenji Amagai
    Keisho Chin
    Yasumasa Niwa
    Akihito Tsuji
    Hiroshi Imamura
    Masahiro Tsuda
    Hirofumi Yasui
    Hirofumi Fujii
    Kensei Yamaguchi
    Hisateru Yasui
    Shuichi Hironaka
    Ken Shimada
    Hiroto Miwa
    Chikuma Hamada
    Ichinosuke Hyodo
    Gastric Cancer, 2017, 20 : 640 - 645
  • [7] Clinical Study of S-1 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Treatment for Elderly Patients with Advanced Gastric Cancer
    Bo Deng-feng
    Hu Xiu-fu
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (04): : 238 - 242
  • [8] A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
    Ueno, M.
    Okusaka, T.
    Omuro, Y.
    Isayama, H.
    Fukutomi, A.
    Ikeda, M.
    Mizuno, N.
    Fukuzawa, K.
    Furukawa, M.
    Iguchi, H.
    Sugimori, K.
    Furuse, J.
    Shimada, K.
    Ioka, T.
    Nakamori, S.
    Baba, H.
    Komatsu, Y.
    Takeuchi, M.
    Hyodo, I.
    Boku, N.
    ANNALS OF ONCOLOGY, 2016, 27 (03) : 502 - 508
  • [9] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
    Hosokawa, Ayumu
    Ando, Takayuki
    Ogawa, Kohei
    Ueda, Akira
    Yoshita, Hiroki
    Mihara, Hiroshi
    Fujinami, Haruka
    Kajiura, Shinya
    Yabushita, Kazuhisa
    Horikawa, Naoki
    Kobayashi, Yuka
    Yoshioka, Akira
    Origasa, Hideki
    Sugiyama, Toshiro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
  • [10] Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naive patients with advanced gastric cancer
    Yamada, Y.
    Higuchi, K.
    Nishikawa, K.
    Gotoh, M.
    Fuse, N.
    Sugimoto, N.
    Nishina, T.
    Amagai, K.
    Chin, K.
    Niwa, Y.
    Tsuji, A.
    Imamura, H.
    Tsuda, M.
    Yasui, H.
    Fujii, H.
    Yamaguchi, K.
    Yasui, H.
    Hironaka, S.
    Shimada, K.
    Miwa, H.
    Hamada, C.
    Hyodo, I.
    ANNALS OF ONCOLOGY, 2015, 26 (01) : 141 - 148
12345